Urgent Alert: Nutex Health Investors Face Critical Deadline in Securities Class Action Lawsuit

A pivotal moment is approaching for investors in Nutex Health, Inc. (NASDAQ: NUTX). Faruqi & Faruqi, LLP, a leading national securities law firm, is issuing a crucial reminder to shareholders regarding the ongoing class action lawsuit. If you purchased Nutex Health stock during the specified period and suffered significant losses, time is of the essence, as a vital deadline looms.

The lawsuit alleges that Nutex Health, Inc., and certain of its senior officers and directors, made materially false and/or misleading statements and/or failed to disclose critical information to the investing public.

Specifically, it claims that the company's financial statements were not accurate, that it failed to maintain effective internal control over financial reporting, and that, consequently, statements made regarding its business, operations, and prospects were misleading or lacked a reasonable basis throughout the class period.

These alleged misrepresentations and omissions are believed to have artificially inflated Nutex Health's stock price, leading to substantial losses for investors when the true state of affairs reportedly came to light.

The lawsuit seeks to recover damages for investors who were harmed by these alleged actions.

The class period in question spans from January 12, 2022, through August 18, 2023, inclusive. Investors who purchased Nutex Health shares within these dates and experienced losses are strongly encouraged to come forward.

Crucially, the deadline to apply to the Court to be appointed as lead plaintiff in this class action lawsuit is September 16, 2024. Becoming a lead plaintiff allows you to play a significant role in directing the litigation and protecting the interests of all class members.

Faruqi & Faruqi, LLP is known for its aggressive pursuit of justice for investors and has recovered hundreds of millions of dollars for shareholders.

If you believe you have a claim, or simply wish to discuss your rights and potential recovery, it is imperative to act quickly. Investors with losses exceeding $100,000 from their investments in Nutex Health during the class period are particularly urged to contact the firm.

For further information, or to discuss your options, please reach out to Faruqi & Faruqi Partner James (Josh) Wilson directly.

You can contact him at 877-247-4292 or 212-983-9330, or via email at jwilson@faruqilaw.com. Don't let this critical deadline pass without understanding your rights and the potential for recovery.